I recall Hardoak mentioned that it could be as early as November 27 this month. I've followed this great mans posts and he is generally on the ball!
FDA issued in their aim statement that they aim for 10 month turnaround and considering Axiron was lodged in January 2010 that sounds about right.
The volume and price appreciation lately would also indicate that FDA decision looms earlier rather than later...
Add to My Watchlist
What is My Watchlist?
